Hoechst 33342 induces radiosensitization in malignant glioma cells via increase in mitochondrial reactive oxygen

Mohammad Athar1, Nabo K Chaudhury, Mohammad E Hussain

  • 1Division of Radiation Biosciences, Institute of Nuclear Medicine and Allied Sciences, Defence R&D Organization, Brig. S. K. Mazumdar Road, Delhi, India.

Free Radical Research
|June 15, 2010
PubMed

Insights

Hoechst 33342 binds to mitochondrial DNA, increasing reactive oxygen species (ROS) and enhancing radiation-induced cancer cell death. This finding aids in developing novel anti-cancer strategies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Mitochondrial DNA (mtDNA) influences cancer therapeutic agent sensitivity.
  • Hoechst 33342, a DNA minor groove binder, exhibits radiosensitizing properties in cancer cells.

Purpose of the Study:

  • Investigate Hoechst 33342 binding to mtDNA in human cerebral glioma (BMG-1) cells.
  • Determine the impact of this binding on reactive oxygen species (ROS) generation in irradiated BMG-1 cells.

Main Methods:

  • Fluorescence spectroscopy to detect Hoechst 33342 binding to isolated mitochondria and mtDNA.
  • Measurement of ROS levels in BMG-1 cells with and without Hoechst 33342, with and without irradiation.
  • Utilized electron transport chain (ETC) complex I inhibitors to probe ROS generation mechanisms.
  • Assessed changes in mitochondrial membrane potential (DeltaPsim) and antioxidant machinery.

Main Results:

  • Fluorescence spectroscopy confirmed Hoechst 33342 binding to isolated mitochondria and mtDNA.
  • Hoechst 33342 alone increased ROS levels, with further enhancement observed in irradiated cells.
  • Mitochondrial-bound Hoechst 33342 was linked to increased ROS, altered DeltaPsim, and modified antioxidant systems.
  • These alterations contributed to potentiated radiation-induced cell death in BMG-1 cells.

Conclusions:

  • Hoechst 33342 binding to mtDNA in glioma cells increases ROS production.
  • This interaction enhances radiosensitivity by affecting mitochondrial function and antioxidant defenses.
  • Findings support the development of targeted anti-cancer strategies involving mitochondrial DNA interactions.